PACS and the corporate gestalt

Article

By Greg Freiherr, Editor, gfreiherr@cmp.comToday's equipment reflects manufacturers' philosophies about how medicine is practiced. This overview has become a prerequisite of

By Greg Freiherr, Editor, gfreiherr@cmp.com

Today's equipment reflects manufacturers' philosophies about how medicine is practiced. This overview has become a prerequisite of techno-evolution, as developers look for ways to improve their products. Whereas engineers once did the doable, creating machines that addressed the furthest reaches of technological capability, they now consider ergonomics and workflow as integral elements of the design.

Differences in design are most apparent in areas where technology has made the greatest gains. PET/CT hybrids are optimized for dual-modality scanning, but these machines also reflect economic and clinical realities by allowing separable operation of the PET and CT components. In CT, vendors are filling the incremental gaps above and below the quad-slice scanners initially introduced, producing multislice scanners over a range of price points and performance levels suited to the needs of just about every buyer.

PACS epitomizes techno-evolutionary thought. PACS automates erstwhile manual steps of recording, storing, and transmitting information. Lately, PACS installations have been crafted with algorithms drawn from human processes of information processing. Not surprisingly, it is here that the impact of corporate ideology--and the potential for opportunity--may be greatest.

While the clinical needs and workflow demands of institutions largely shape the choice of hybrid scanners and multislice CTs, workflow at individual institutions has only limited impact on the choice of a PACS. Only rough indicators, such as the annual number of procedures and the types of modalities, are being factored in. Scalability often is the common denominator of product offerings, and customers as individual vendors impose a singular philosophy or approach on multiple products differentiated primarily by their ability to handle a volume of work.

In this market, the wise buyer looks at the constructs built into these systems, the philosophy behind them, and the training and support programs that turn machines into clinical practice.

The opportunity exists for companies to identify the best and brightest PACS and to use acquisitions to build these offerings into a product line with multiple offerings tailored to different needs. It will require flexibility in corporate philosophy and a dedication to the broader goals of medical practice. But doing so could be a boon for customer and corporation alike.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.